Accuri C6 Flow Cytometer System
Originally published online as doi:10.1189/jlb.0208088 on July 24, 2008

Published online before print July 24, 2008
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Supplemental Figures 1 & 2; Table 1
Right arrow Supplemental Movies
Right arrow All Versions of this Article:
jlb.0208088v1
84/4/1130    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hartmann, T. N.
Right arrow Articles by Alon, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartmann, T. N.
Right arrow Articles by Alon, R.
(Journal of Leukocyte Biology. 2008;84:1130-1140.)
© 2008 by Society for Leukocyte Biology

A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells

Tanja Nicole Hartmann*,{dagger}, Valentin Grabovsky*, Ronit Pasvolsky*, Ziv Shulman*, Eike C. Buss*,{ddagger}, Asaf Spiegel*, Arnon Nagler§, Tsvee Lapidot*, Marcus Thelen|| and Ronen Alon*,1

* Department of Immunology, Weizmann Institute of Science, Rehovot, Israel;
§ Department of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel;
|| Institute for Research in Biomedicine, Bellinzona, Switzerland;
{dagger} Laboratory for Immunological and Molecular Cancer Research, Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology of the Paracelsus Medical University Salzburg, Salzburg, Austria; and
{ddagger} Department of Internal Medicine V, University of Heidelberg, Germany

1 Correspondence: Department of Immunology, The Weizmann Institute of Science, Rehovot, 76100, Israel. E-mail: ronen.alon{at}weizmann.ac.il

The chemokine CXCL12 promotes migration of human leukocytes, hematopoietic progenitors, and tumor cells. The binding of CXCL12 to its receptor CXCR4 triggers Gi protein signals for motility and integrin activation in many cell types. CXCR7 is a second, recently identified receptor for CXCL12, but its role as an intrinsic G-protein-coupled receptor (GPCR) has been debated. We report that CXCR7 fails to support on its own any CXCL12-triggered integrin activation or motility in human T lymphocytes or CD34+ progenitors. CXCR7 is also scarcely expressed on the surface of both cell types and concentrates right underneath the plasma membrane with partial colocalization in early endosomes. Nevertheless, various specific CXCR7 blockers get access to this pool and attenuate the ability of CXCR4 to properly rearrange by surface-bound CXCL12, a critical step in the ability of the GPCR to trigger optimal CXCL12-mediated stimulation of integrin activation in T lymphocytes as well as in CD34+ cells. In contrast, CXCL12-triggered CXCR4 signaling to early targets, such as Akt as well as CXCR4-mediated chemotaxis, is insensitive to identical CXCR7 blocking. Our findings suggest that although CXCR7 is not an intrinsic signaling receptor for CXCL12 on lymphocytes or CD34+ cells, its blocking can be useful for therapeutic interference with CXCR4-mediated activation of integrins.

Key Words: adhesion molecules • cell trafficking • shear • endothelium • migration




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. E. Bamberg, C. R. Mackay, H. Lee, D. Zahra, J. Jackson, Y. S. Lim, P. L. Whitfeld, S. Craig, E. Corsini, B. Lu, et al.
The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction
J. Biol. Chem., March 5, 2010; 285(10): 7633 - 7644.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. Arms, B. M. Girard, and M. A. Vizzard
Expression and function of CXCL12/CXCR4 in rat urinary bladder with cyclophosphamide-induced cystitis
Am J Physiol Renal Physiol, March 1, 2010; 298(3): F589 - F600.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. Tarnowski, K. Grymula, R. Reca, K. Jankowski, R. Maksym, J. Tarnowska, G. Przybylski, F. G. Barr, M. Kucia, and M. Z. Ratajczak
Regulation of Expression of Stromal-Derived Factor-1 Receptors: CXCR4 and CXCR7 in Human Rhabdomyosarcomas
Mol. Cancer Res., January 1, 2010; 8(1): 1 - 14.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. Campana, L. Bosurgi, M. E. Bianchi, A. A. Manfredi, and P. Rovere-Querini
Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells
J. Leukoc. Biol., September 1, 2009; 86(3): 609 - 615.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. A. Zabel, Y. Wang, S. Lewen, R. D. Berahovich, M. E. T. Penfold, P. Zhang, J. Powers, B. C. Summers, Z. Miao, B. Zhao, et al.
Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands
J. Immunol., September 1, 2009; 183(5): 3204 - 3211.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Levoye, K. Balabanian, F. Baleux, F. Bachelerie, and B. Lagane
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
Blood, June 11, 2009; 113(24): 6085 - 6093.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. E. Luker, M. Gupta, and G. D. Luker
Imaging chemokine receptor dimerization with firefly luciferase complementation
FASEB J, March 1, 2009; 23(3): 823 - 834.
[Abstract] [Full Text] [PDF]